Aspect Biosystems Releases Preclinical Data Highlighting the Potential of Adrenal Bioprinted Tissue Therapeutics
Aspect Biosystems has released preclinical data highlighting the potential of their adrenal Bioprinted Tissue Therapeutics to restore adrenal function and treat primary adrenal insufficiency.
Primary adrenal insufficiency is a serious, life-threatening condition in which the adrenal glands fail to produce sufficient levels of essential hormones such as cortisol, a key regulator of the body's stress response.